Deferiprone

FDA Approved: * February 8, 2019
Pharm Company: * TARO PHARM INDS LTD
Category: Iron Chelator

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Deferiprone Overview

Deferiprone (tradenames include Ferriprox) is a drug that chelates iron and is used to treat iron overload in thalassaemia major.[1] It was first approved for use in treating thalassaemia major in 1994[2] and had been licensed for use in Europe and Asia for many years while awaiting approval in Canada and the United States.[1] On October 14, 2011, it was approved for use in the US under the FDA's accelerated approval program.[3]...

Read more Deferiprone Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Deferiprone

Recent Deferiprone Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Deferiprone: (1 result)

Sorted by National Drug Code

• 51672-4196 Deferiprone 500 mg Oral Tablet by Taro Pharmaceuticals U.S.a., Inc.

Other drugs which contain Deferiprone or a similar ingredient: (1 result)

• FERRIPROX Deferiprone1 discussion